Search research articles
Contact Us
Filters
Showing results (21-30 of 140) with videos related to
Page
of 14
Sort By:
Thrombosis Research
|
July 1, 1981
Stimulation of coronary vascular prostacyclin and inhibition of human platelet thromboxane A2 after low-dose nitroglycerin
K Schrör, L Grodzinska, H Darius
Biomedica Biochimica Acta
|
January 1, 1984
Stereospecific stimulation of coronary vascular PGI2 by organic nitrates--studies with the new compound teopranitol (KC-046)
H Darius, P Weiss, K Schrör
Klinische Wochenschrift
|
June 16, 1986
Antiplatelet effects of intravenous iloprost in patients with peripheral arterial obliterative disease. A placebo-controlled dose-response study
H Darius, V Hossmann, K Schrör
Thrombosis Research
|
June 1, 1993
Synergistic platelet antiaggregatory effects of the adenylate cyclase activator iloprost and the guanylate cyclase activating agent SIN-1 in vivo
M Spiecker, H Darius, J Meyer
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1981
Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia
K Schrör, R Ohlendorf, H Darius
Journal of Cardiovascular Pharmacology
|
August 1, 1987
Cardiovascular actions in vitro and cardioprotective effects in vivo of nileprost, a mixed type PGI2/PGE2 agonist
H Darius, T Thomsen, K Schrör
European Journal of Clinical Pharmacology
|
January 1, 1992
The effects of the nitric oxide donors molsidomine and SIN-I on human polymorphonuclear leucocyte function in vitro and ex vivo
H Darius, L Grodzinska, J Meyer
Der Internist
|
March 11, 2000
[Pharmacology of NSAIDS]
M Buerke, H Darius, J Meyer
Thrombosis and Haemostasis
|
November 30, 1990
Effect of molsidomine on t-PA and PAI activity in man: a double blind, placebo controlled study
L Grodzinska, G Hafner, H Darius
Arzneimittel-Forschung
|
January 1, 1982
The release of prostacyclin (PGI2) by pentoxifylline from human vascular tissue
R Matzky, H Darius, K Schrör
Page
of 14
Search research articles
Search
Showing results (21-30 of 140) with videos related to
Sort By:
Page
of 14
Thrombosis Research
|
July 1, 1981
Stimulation of coronary vascular prostacyclin and inhibition of human platelet thromboxane A2 after low-dose nitroglycerin
K Schrör, L Grodzinska, H Darius
Biomedica Biochimica Acta
|
January 1, 1984
Stereospecific stimulation of coronary vascular PGI2 by organic nitrates--studies with the new compound teopranitol (KC-046)
H Darius, P Weiss, K Schrör
Klinische Wochenschrift
|
June 16, 1986
Antiplatelet effects of intravenous iloprost in patients with peripheral arterial obliterative disease. A placebo-controlled dose-response study
H Darius, V Hossmann, K Schrör
Thrombosis Research
|
June 1, 1993
Synergistic platelet antiaggregatory effects of the adenylate cyclase activator iloprost and the guanylate cyclase activating agent SIN-1 in vivo
M Spiecker, H Darius, J Meyer
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1981
Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia
K Schrör, R Ohlendorf, H Darius
Journal of Cardiovascular Pharmacology
|
August 1, 1987
Cardiovascular actions in vitro and cardioprotective effects in vivo of nileprost, a mixed type PGI2/PGE2 agonist
H Darius, T Thomsen, K Schrör
European Journal of Clinical Pharmacology
|
January 1, 1992
The effects of the nitric oxide donors molsidomine and SIN-I on human polymorphonuclear leucocyte function in vitro and ex vivo
H Darius, L Grodzinska, J Meyer
Der Internist
|
March 11, 2000
[Pharmacology of NSAIDS]
M Buerke, H Darius, J Meyer
Thrombosis and Haemostasis
|
November 30, 1990
Effect of molsidomine on t-PA and PAI activity in man: a double blind, placebo controlled study
L Grodzinska, G Hafner, H Darius
Arzneimittel-Forschung
|
January 1, 1982
The release of prostacyclin (PGI2) by pentoxifylline from human vascular tissue
R Matzky, H Darius, K Schrör
Page
of 14